| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","as_of":"2026-04-07T03:18:43.308311+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","company":"Cartesian Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","article_chars":2572,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_2bb6326d66bd3b6d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","content_type":"text/plain","enriched_at":"2026-04-07T10:22:12.283195+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt","source_event_id":"evt_dbf5a8324e11","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"fc8a3a1760684932","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-02","2026-04-06","2023-11-13"],"entities":[{"asset_class":"equity","name":"Cartesian Therapeutics, Inc.","relevance":"high","symbol":"CART","type":"company"}],"event_type":"listing","information_gaps":["No specific number of shares converted was provided.","Details on the beneficial ownership limitation are not specified."],"key_facts":["Form 4 filed on April 6, 2026.","Reporting owner: Murat Kalayoglu.","Conversion of Series A Non-Voting Convertible Preferred Stock into common stock occurred on April 2, 2026."],"numeric_claims":[],"primary_claim":"Murat Kalayoglu's trust converted Series A Non-Voting Convertible Preferred Stock into common stock on April 2, 2026.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"Murat Kalayoglu filed a Form 4 disclosing changes in beneficial ownership of securities for Cartesian Therapeutics, Inc., including the conversion of Series A Non-Voting Convertible Preferred Stock into common stock.","topics":["SEC Filing","Ownership Change","Cartesian Therapeutics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Cartesian Therapeutics, Inc. \u00b7 Filed 20260406","ticker":"RNAC","tickers":["RNAC"],"title":"RNAC filed 4","url":"https://www.sec.gov/Archives/edgar/data/1453687/0002064832-26-000148.txt"}... |